FibroHeal Woundcare is a silk protein-based medical device startup that raised Rs 6.3 crore in its pre-series A funding round from its new and existing promoters. The funding round also saw investment from medical professionals, bankers, and surgeons. The startup plans to use these fresh proceeds to scale its operations, recruit more people, expand its network, and develop a market presence. The company will use some of this investment to improve its go-to-market strategy and enhance its platform services.
The startup offers innovative solutions and develops silk proteins as biomaterials for wound healing. FibroHeal uses biomaterial application of silk proteins for advanced and active wound care products to heal chronic and acute wounds. The startup aims to provide top healthcare solutions to its customers with a product range addressing various stages of wounds. The platform is designed to empower healthcare and medical professionals by offering innovative healthcare solutions.
FirbroHeal Woundcare wants to revolutionize healthcare management and improve its product pipeline in the medical devices segment. This Bengaluru-based startup has raised around 1.59 million USD across seven funding rounds since its inception, including $552k secured during its seed funding round from KITVEN, Karnataka Trustee, and other investors. The firm offers its products in more than 500 hospitals across India. The company claims to provide its products through its centers in 19 states and various e-commerce platforms.
The startup currently provides products including mesh, foams, and powders to treat different wounds like acute, traumatic, chronic, non-healing, and others. This investment will enable the health-tech startup to enhance its market presence and boost its product development while developing new treatment solutions. The company focuses on expanding its services and product line. The company also committed a Rs 10 crore round from its new and existing investors.
The investment shows the Investor’s trust in Fibroheal Woundcare’s market potential and business model. This startup provides the best healthcare-related solutions and helps patients treat wounds even if its infection c-section wounds. The startup provides solutions across different sectors including in the healthtech market. The company faces competition from other healthtech companies including OSPT, Serigen, and KLISBio. The startup aims to become a leading player in the healthtech industry and receives investment from CCAMP, Telama Investments, and KITVEN.
Conclusion :
Fibroheal Woundcare is a healthtech startup that secured Rs 6.3 crore in its pre-series A funding round. The funding round saw the participation firm’s existing and new investors including some surgeons, bankers, and medical professionals. This healthtech startup intends to use this fresh capital to scale its business, increase its product pipeline in the medical device sector, hire more people, and enhance its platform while developing healthcare solutions.
The firm offers its products through e-commerce platforms and its stores in around 19 states across India. The company aims to revolutionize the healthtech sector and wound treatment industry. The company offers its products in over 500 hospitals. The Bengaluru-based startup has secured around $1.59 million to date, excluding the recent funding round, and it competes with companies like Serigen.
Niraj Kumar is the Founder and CEO of Scoopearth, bringing over 13 years of experience across diverse domains, including journalism, content marketing, digital marketing, startup mentoring, and business coaching. His extensive background and leadership have made a significant impact in these areas, helping startups grow and succeed in a competitive landscape.
Reach us: niraj@scoopearth.com
Linkedin Profile: https://www.linkedin.com/in/digitalnirajj/
Disclaimer -We have collected this information from our direct sources, various trustworthy sources on the internet and the facts have been checked manually and verified by our in-house team.
0 Comments